SCHEDULE: Dodge & Cox Boosts Elanco Stake to 15.9%
Beneficial Ownership Report
Dodge & Cox, an investment adviser, has reported a 15.9% beneficial ownership stake in Elanco Animal Health Incorporated's common stock.
Summary
- Dodge & Cox, an investment adviser, beneficially owns 79,084,305 shares of Elanco Animal Health Incorporated's Common Stock.
- This ownership represents 15.9% of the class of securities.
- Dodge & Cox holds sole voting power over 75,198,905 shares and sole dispositive power over 79,084,305 shares.
- A significant portion of this holding, 53,122,900 shares (10.7% of the class), is held by Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a large, passive stake by a reputable investment adviser like Dodge & Cox suggests a long-term conviction in Elanco's value, without indicating any immediate operational changes or challenges.
Industry Context
StockSavvy.ai notes that a Schedule 13G filing indicates a passive institutional investment, signifying a significant vote of confidence from a major investment adviser like Dodge & Cox in Elanco Animal Health. Such large institutional holdings are common in the animal health sector, which often attracts long-term investors due to its defensive characteristics and growth potential.
Stakeholder Impact
- Shareholders: Increased institutional ownership can provide stability and potentially attract further investor interest, signaling confidence in the company's long-term prospects.
- Company Management: A large passive stake from a respected firm like Dodge & Cox can be seen as an endorsement of current strategy, though it also means a significant portion of the voting power is concentrated.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement |
| 02/13/2026 | Date of filing |
Keywords
Elanco Animal Health, Dodge & Cox, Beneficial Ownership, Institutional Investor, Common Stock, Investment Adviser, ELANCO, Animal Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.